Acutaas Chemicals Ltd.
NSE: ACUTAAS | BSE: 543349
₹2,912.50
₹31.90
(1.11%)
As on 21-May-2026 09:29IST
Market cap
₹23,624 Cr
Revenue (TTM)
₹1,339 Cr
P/E Ratio
66.3
P/B Ratio
14.3
Div. Yield
0.1 %
Quality Score
8/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹356 Cr
-
ROE
16.2 %
-
ROCE
20.1 %
-
Industry P/E
44.31
-
EV/EBITDA
44.9
-
Debt to Equity
--
-
Book Value
₹202
-
EPS
₹43.5
-
Face value
5
-
Shares outstanding
81,871,122
10 Years Aggregate
CFO
₹371.92 Cr
EBITDA
₹823.43 Cr
Net Profit
₹512.32 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Acutaas Chemicals
| 70.8 | 20.8 | 38.3 | 147.1 | 71.2 | -- | -- |
|
BSE Healthcare
| 10.5 | 10.6 | 11.4 | 13.7 | 28.2 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Acutaas Chemicals
| 63.5 | 87.8 | 16.2 | -9.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Acutaas Chemicals
|
2,912.5 | 23,623.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 66.3 | 14.3 |
| 512.7 | 8,094.0 | 4,359.0 | 256.4 | 8.4 | 8.3 | 31.7 | 2.4 | |
| 748.9 | 14,795.3 | 7,344.9 | 670.6 | 10.9 | 13.7 | 21.9 | 2.6 | |
| 425.5 | 16,083.1 | 2,268.6 | 150.1 | 10.6 | 5.4 | 89.7 | 4.1 | |
| 757.6 | 18,792.9 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.6 | 3.7 | |
| 1,860.0 | 21,411.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.7 | |
| 175.2 | 23,447.9 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 183.2 | 5,950.1 | 1,879.2 | 1,553.2 | 84.5 | -- | 3.8 | 4.4 | |
| 471.1 | 18,823.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.4 | 3.9 | |
| 1,607.9 | 26,182.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.9 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
3 min read•By Udhayaprakash
Ami Organics IPO: Information analysis
6 min read•By Danish Khanna and Udhayaprakash
About Acutaas Chemicals
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical... ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation, salicylic acid, and other special chemicals that are used in cosmetics, dyes, polymers and agrochemical, animal foods, and personal care industries. Acutaas Chemicals Limited exports its products. Acutaas Chemicals Limited was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. The company was founded in 2004 and is based in Surat, India. Read more
-
Incorporated
2007
-
Chairman
Nareshkumar Patel
-
Managing Director
Nareshkumar Patel
-
Headquarters
Surat, Gujarat
-
Website
Looking for more details about Acutaas Chemicals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
30-Apr-2026No News & Announcements are available.
FAQs for Acutaas Chemicals
What is the current share price of Acutaas Chemicals Ltd Today?
The share price of Acutaas Chemicals Ltd is ₹2,912.50 (NSE) and ₹2,955.55 (BSE) as of 21-May-2026 09:29 IST. Acutaas Chemicals Ltd has given a return of 71.21% in the last 3 years.
What is the current PB & PE ratio of Acutaas Chemicals Ltd?
The P/E ratio of Acutaas Chemicals Ltd is 66.31 times as on 20-May-2026, a 50 premium to its peers’ median range of 44.31 times.
The P/B ratio of Acutaas Chemicals Ltd is 14.29 times as on 20-May-2026, a 267 premium to its peers’ median range of 3.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
62.97
|
15.26
|
|
2024
|
47.18
|
6.01
|
|
2023
|
19.44
|
5.45
|
|
2022
|
50.63
|
6.97
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Acutaas Chemicals Ltd?
The 52-week high and low of Acutaas Chemicals Ltd are Rs 2,924.90 and Rs 1,059.00 as of 21-May-2026.
What is the market cap of Acutaas Chemicals Ltd?
Acutaas Chemicals Ltd has a market capitalisation of ₹ 23,624 Cr as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Acutaas Chemicals Ltd?
Before investing in Acutaas Chemicals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.